{"id":3641,"date":"2023-06-12T07:00:00","date_gmt":"2023-06-12T05:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/annualreport\/press-releases\/ipsen-to-present-new-data-on-clinical-outcomes-and-patient-validation-tools-from-growing-rare-liver-disease-portfolio-at-easl-2023-3\/"},"modified":"2023-06-12T07:00:00","modified_gmt":"2023-06-12T05:00:00","slug":"ipsen-to-present-new-data-on-clinical-outcomes-and-patient-validation-tools-from-growing-rare-liver-disease-portfolio-at-easl-2023-3","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/annualreport\/press-releases\/ipsen-to-present-new-data-on-clinical-outcomes-and-patient-validation-tools-from-growing-rare-liver-disease-portfolio-at-easl-2023-3\/","title":{"rendered":"Ipsen to present new data on clinical outcomes and patient validation tools from growing rare liver disease portfolio at EASL 2023"},"content":{"rendered":"